Israel Bio-pharma Research Market is Expected to Grow at a CAGR of 7.4% to Reach USD 659.2 Million by 2020

"The report “Israel Bio-pharma Research Market [Product {Consumables-Assay, Kits and Reagent, Cell Line, Instrument {Separation, Imaging}, Software, Services], [End User {Biotechnology/Biopharmaceutical Company/ CROs, Academic and Research institute}]-Forecast to 2020”, defines and segments the Israel Bio-pharma Research Market with analysis and forecasting of global revenue. It also identifies the driving and restraining factors of the market with analysis of trends, opportunities, and challenges."

The Israel bio-pharma research market is expected to grow at a CAGR of 7.4% to reach USD 659.2 million by 2020. Increasing number of pharmaceutical and biotechnology start-ups, government support, availability of sufficient venture capital (VC) funds, and availability of skilled, educated, and diverse workforce are the major factors driving the Israel medical devices market. However, government regulations (such as drug pricing) are the major factors restraining the growth of this market.

Inquiry Before Buying -

On the basis of product & services, and end users the Israel bio-pharma research market is categorized into different segments. Instruments, consumables, bioreactors, services, and software are product and services segments of Israel bio-pharma research market. Among these segments, the consumables market is expected to dominate the Israel bio-pharma research market in 2015. Increasing usage of consumables, along with automation and advancements in detection technologies are the major drivers for consumables market. The software market is expected to witness the highest growth during the forecast period, attributed to the advancements in bioinformatics tools.

Based on end users, the market is sub segmented into biotechnology/biopharmaceutical companies/CROs and academic and research institutes. The biotechnology/biopharmaceutical companies/CROs segment is expected to account for the largest share of the Israel bio-pharma research market in 2015. The largest share is attributed to factors such as the technological advancements, increased investments from governments, and private companies.

Download PDF For More Information -

An in-depth market share analysis, by revenue, of the top companies is included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives. Top market players that have established their base in the Israel bio-pharma research market are Thermo Fisher Scientific Inc. (U.S.), Merck KGAA (Germany), Perkinelmer Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson and Company (U.S.)

Report Subscription:

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.


Mr. Chandrasekhar K. 

UNIT no 802, Tower No. 7, SEZ

Magarpatta City, Hadapsar

Pune, Maharashtra 411013,

India 1-888-502-0539